M
Mar Lorente
Researcher at Complutense University of Madrid
Publications - 57
Citations - 10132
Mar Lorente is an academic researcher from Complutense University of Madrid. The author has contributed to research in topics: Cannabinoid & Cancer. The author has an hindex of 29, co-authored 54 publications receiving 8292 citations. Previous affiliations of Mar Lorente include Spanish National Research Council & Salisbury University.
Papers
More filters
Journal ArticleDOI
MicroRNA let-7d is a target of cannabinoid CB1 receptor and controls cannabinoid signaling.
Anna Chiarlone,Christine Börner,Laura Martín-Gómez,Ada Jimenez-Gonzalez,Adrián García-Concejo,María Laura García-Bermejo,Mar Lorente,Cristina Blázquez,Elena García-Taboada,Amador Haro,Elisa Martella,Volker Höllt,Raquel E. Rodríguez,Ismael Galve-Roperh,Jürgen Kraus,Manuel Guzmán +15 more
TL;DR: These findings provide the first evidence for a bidirectional link between the CB1 receptor and a microRNA, namely let-7d, and thus unveil a new player in the complex process of cannabinoid action.
Journal ArticleDOI
Stromal SNAI2 is required for ERBB2 breast cancer progression
Adrián Blanco-Gómez,Lourdes Hontecillas-Prieto,Roberto Corchado-Cobos,Natalia García-Sancha,Nélida Salvador,Andrés Castellanos-Martín,María del Mar Sáez-Freire,Marina Mendiburu-Eliçabe,Diego Alonso-López,Javier De Las Rivas,Mar Lorente,Ana García-Casas,Sofía Del Carmen,María del Mar Abad-Hernández,Juan J. Cruz-Hernández,César Augusto Rodríguez-Sánchez,Juncal Claros-Ampuero,Begoña García-Cenador,Javier García-Criado,Akira Orimo,Thomas Gridley,Jesús Pérez-Losada,Sonia Castillo-Lluva +22 more
TL;DR: The loss of SNAI2 in cancer-associated fibroblasts limits the production of some cytokines, which influences AKT/ERK tumor signaling and subsequent proliferative and metastatic capacity of ERBB2+ breast cancer cells.
Journal ArticleDOI
TRIB3 suppresses tumorigenesis by controlling mTORC2/AKT/FOXO signaling.
María Salazar,Mar Lorente,Elena García-Taboada,Eduardo Perez Gomez,David Dávila,Patricia Zúñiga-García,Juana M. Flores,Antonio Niño Rodríguez,Zoltan Hegedus,David Mosen-Ansorena,Ana M. Aransay,Sonia Hernández-Tiedra,Israel López-Valero,Miguel Quintanilla,Cristina Sánchez,Juan L. Iovanna,Nelson Dusetti,Manuel Guzmán,Sheila E. Francis,Arkaitz Carracedo,Endre Kiss-Toth,Guillermo Velasco +21 more
TL;DR: It is found that Tribbles pseudokinase 3 (TRIB3) plays a tumor suppressor role and that this effect relies on the dysregulation of the phosphorylation of v-akt murine thymoma viral oncogene homolog (AKT) by the mammalian target of rapamycin complex 2 (mTORC2 complex), and the subsequent hyperphosphorylation and inactivation of the transcription factor Forkhead box O3 (FOXO3).
Patent
Cannabinoids in combination with non-cannabinoid chemotherapeutic agents (e.g. serm or alkylating agents)
TL;DR: In this paper, the use of one or more cannabinoids, particularly THC and/or CBD in combination with a non-cannabinoid chemotherapeutic agent in the manufacture of a medicament for use in the treatment of cancer.
Journal ArticleDOI
Oncosuppressive functions of tribbles pseudokinase 3
María Salazar,Mar Lorente,Alba Orea-Soufi,David Dávila,Tatiana Erazo,Jose M. Lizcano,Arkaitz Carracedo,Arkaitz Carracedo,Endre Kiss-Toth,Guillermo Velasco +9 more
TL;DR: Observation obtained by laboratories supporting that TRIB3 plays a crucial role in the anti-cancer activity of cannabinoids (a novel family of potential anti- cancer agents derived from marijuana) and thatTRIB3 genetic inactivation enhances cancer generation and progression are summarized.